When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRNX - Crinetics Pharma's paltusotine an Orphan Drug in U.S. for growth hormone disorder
Crinetics Pharmaceuticals Inc.
The FDA designates Crinetics Pharmaceuticals' (NASDAQ:CRNX) paltusotine an Orphan Drug for the treatment of acromegaly, a disorder in which the pituitary gland secretes too much growth hormone resulting in excessive bone growth, typically in the face, feet and hands.
More news on: Crinetics Pharmaceuticals, Inc., Healthcare stocks news,